Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

Other biomarkers, such as blood selenium, manganese and vitamin D, did not show significant differences between the cohorts (Table 3).

Source: Laboratory results. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Study design awaiting verification.

Study design awaiting verification

The available source does not establish a sufficiently clear study design.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Children aged 12 to 24 months (pre-pandemic: n 3 904 863; pandemic: n 3 496 904).

Source: Abstract.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Impact of the COVID-19 pandemic on growth, nutrition and immune function in infants and toddlers

Study design awaiting verification · Public Health Nutrition · 2026

Original publication title

Impact of the COVID-19 pandemic on growth, nutrition and immune function in infants and toddlers

Yingli Lin; Dongshui Kang; Qi Chen; Shuang Chen

© The Author(s) 2026

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

The COVID-19 pandemic did not substantially alter growth, nutrition or immune function in infants and toddlers, though micronutrient intakes and toxin exposure shifted. Long-term monitoring is warranted.

An extract from the source publication. Read it in context.

At a glance

Abstract: What objectives does the paper state?

To evaluate the impact of the COVID-19 pandemic on physical growth, nutritional intake and immune function in children aged 12 to 24 months.

Source: Objective:

Abstract: Design

A cross-sectional analysis was conducted utilising data from the National Health and Nutrition Examination Survey (NHANES). Pre-pandemic (2017 to 2018) and pandemic (2021 to 2023) cohorts were compared.

Source: Design:

Abstract: Setting

Nationally representative data from the United States.

Source: Setting:

Abstract: Participants

Children aged 12 to 24 months (pre-pandemic: n 3 904 863; pandemic: n 3 496 904).

Source: Participants:

Abstract: Results

No significant differences were observed in physical growth (weight, length and BMI) or macronutrient intake between cohorts. Pandemic-born children had lower vitamin A (437·0 v. 540·0 mcg/d, P = 0·006) and B12 (2·7 v. 3·4 mcg/d, P = 0·009) intake but higher vitamin C intake (87·0 v. 62·8 mg/d, P < 0·001). Inflammatory markers (neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio and systemic immune-inflammation index) showed minor age: and sex-specific variations but remained within normal ranges. Environmental toxin exposure (cadmium and mercury) was significantly reduced during the pandemic.

Source: Results:

Abstract: Conclusions

The COVID-19 pandemic did not substantially alter growth, nutrition or immune function in infants and toddlers, though micronutrient intakes and toxin exposure shifted. Long-term monitoring is warranted.

Source: Conclusions:
Authors’ abstract

Objective:

To evaluate the impact of the COVID-19 pandemic on physical growth, nutritional intake and immune function in children aged 12 to 24 months.

Design:

A cross-sectional analysis was conducted utilising data from the National Health and Nutrition Examination Survey (NHANES). Pre-pandemic (2017 to 2018) and pandemic (2021 to 2023) cohorts were compared.

Setting:

Nationally representative data from the United States.

Participants:

Children aged 12 to 24 months (pre-pandemic: n 3 904 863; pandemic: n 3 496 904).

Results:

No significant differences were observed in physical growth (weight, length and BMI) or macronutrient intake between cohorts. Pandemic-born children had lower vitamin A (437·0 v. 540·0 mcg/d, P = 0·006) and B12 (2·7 v. 3·4 mcg/d, P = 0·009) intake but higher vitamin C intake (87·0 v. 62·8 mg/d, P < 0·001). Inflammatory markers (neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio and systemic immune-inflammation index) showed minor age: and sex-specific variations but remained within normal ranges. Environmental toxin exposure (cadmium and mercury) was significantly reduced during the pandemic.

Conclusions:

The COVID-19 pandemic did not substantially alter growth, nutrition or immune function in infants and toddlers, though micronutrient intakes and toxin exposure shifted. Long-term monitoring is warranted.

Publication and source details

Original title: Impact of the COVID-19 pandemic on growth, nutrition and immune function in infants and toddlers

Yingli Lin; Dongshui Kang; Qi Chen; Shuang Chen

Public Health Nutrition · 2026

Corresponding author: Shuang Chen; Email: xuping120120@163.com

Yingli Lin & Dongshui Kang contributed equally to this work and should be considered as co-first authors.

© The Author(s) 20262026The Author(s)https://creativecommons.org/licenses/by/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-10T22:21:32.528089+00:00

DOI: 10.1017/s1368980026102808 · PMC13434489